Schedule 13D ownership disclosure
ENZO BIOCHEM INC
Common Stock, par value $0.01 per share · CUSIP: 294100102
Event date: 2025-06-23
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Radoff Family FoundationReported CIK 0001496916
Shares: 430,000.00 · Class: 0.8%
- Radoff Bradley LouisReported CIK 0001380585
Shares: 4,820,882.00 · Class: 9.2%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000921895-25-001834
- Form type
- SCHEDULE 13D/A
- Filer
- ENZO BIOCHEM INC
- CIK
- CIK 316253
- Filed
- Jun 25, 2025
- Reporting period
- Jun 23, 2025
- Description
- Schedule 13D beneficial ownership